首页 > 最新文献

Case Reports in Gastroenterology最新文献

英文 中文
A Rapid Development of Post-Colonoscopy Appendicitis within Twelve Hours: A Case Report. 十二小时内迅速发展的结肠镜术后阑尾炎:病例报告。
IF 0.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-06-18 eCollection Date: 2024-01-01 DOI: 10.1159/000538970
Sean-Patrick Prince, Qitan Huang, Denisse Camille Dayto, Andrew Sephien, Varun Patel, Sreekanth Chandrupatla

Introduction: Colon cancer has seen a steady decline in incidence due to increased colonoscopy use. We can assume that this increased use, results in a higher incidence of post-colonoscopy complications such postpolypectomy syndrome, perforation and post-colonoscopy appendicitis (PCA). In this report, we present a case of PCA presenting to the emergency department within 12 h of a screening colonoscopy.

Case presentation: Our patient, a 77-year-old male, underwent an uncomplicated screening colonoscopy and was discharged home after briefly being monitored without any complaints. Later that day, the patient presented to the emergency department complaining of acute generalized abdominal pain. On presentation, the patient was found to be hypertensive and febrile with a distended abdomen with right lower quadrant tenderness on examination. Laboratory investigations noted an elevated white blood cell count with no evidence of acute appendicitis or focal inflammatory changes on contrast-enhanced abdominal and pelvic computer tomography. The patient was subsequently admitted and developed worsening right lower quadrant abdominal pain and distention overnight. Due to this worsening clinical condition, the decision was made to proceed with a diagnostic laparoscopy. After frank pus was found laparoscopically around the cecum and appendix, it was then converted to an exploratory laparotomy. Subsequently, a perforated gangrenous appendix was found with an erythematous and indurated cecum.

Conclusion: Major complications of colonoscopy can include perforation and/or post-colonoscopy bleeding which have been shown to have a respective incidence of 0.21% and 0.1%. With the anticipated rise in the number of colonoscopies, much rarer complications such as PCA with an incidence of less than 0.05% will be seen more frequently. Due to its nonspecific presentation, it is necessary for providers to consider PCA as an important differential for all patients presenting with abdominal pain after a colonoscopy.

导言:由于结肠镜检查的增加,结肠癌的发病率稳步下降。我们可以认为,结肠镜使用率的增加导致结肠镜检查后并发症(如息肉切除术后综合征、穿孔和结肠镜检查后阑尾炎(PCA))的发生率增加。在本报告中,我们介绍了一例在结肠镜检查后 12 小时内到急诊科就诊的 PCA 病例:我们的患者是一名 77 岁的男性,接受了一次并不复杂的结肠镜筛查,在接受短暂监测后出院回家,没有任何不适。当天晚些时候,患者来到急诊科,主诉急性全身腹痛。就诊时发现患者高血压、发热,腹部胀痛,检查时有右下腹压痛。实验室检查发现白细胞计数升高,但没有急性阑尾炎的迹象,腹部和盆腔计算机断层扫描造影剂增强检查也没有发现局灶性炎症病变。患者随后入院,一夜之间右下腹疼痛和腹胀加剧。由于临床症状恶化,医生决定对患者进行腹腔镜诊断。腹腔镜检查发现盲肠和阑尾周围有脓液,于是转为探查性开腹手术。随后,发现阑尾坏疽穿孔,盲肠红肿、化脓:结肠镜检查的主要并发症包括穿孔和/或结肠镜检查后出血,其发生率分别为 0.21% 和 0.1%。随着结肠镜检查数量的预期增长,PCA 等发生率低于 0.05% 的罕见并发症将更加常见。由于 PCA 并无特异性表现,因此对于所有在结肠镜检查后出现腹痛的患者,医疗服务提供者有必要将其作为重要的鉴别依据。
{"title":"A Rapid Development of Post-Colonoscopy Appendicitis within Twelve Hours: A Case Report.","authors":"Sean-Patrick Prince, Qitan Huang, Denisse Camille Dayto, Andrew Sephien, Varun Patel, Sreekanth Chandrupatla","doi":"10.1159/000538970","DOIUrl":"10.1159/000538970","url":null,"abstract":"<p><strong>Introduction: </strong>Colon cancer has seen a steady decline in incidence due to increased colonoscopy use. We can assume that this increased use, results in a higher incidence of post-colonoscopy complications such postpolypectomy syndrome, perforation and post-colonoscopy appendicitis (PCA). In this report, we present a case of PCA presenting to the emergency department within 12 h of a screening colonoscopy.</p><p><strong>Case presentation: </strong>Our patient, a 77-year-old male, underwent an uncomplicated screening colonoscopy and was discharged home after briefly being monitored without any complaints. Later that day, the patient presented to the emergency department complaining of acute generalized abdominal pain. On presentation, the patient was found to be hypertensive and febrile with a distended abdomen with right lower quadrant tenderness on examination. Laboratory investigations noted an elevated white blood cell count with no evidence of acute appendicitis or focal inflammatory changes on contrast-enhanced abdominal and pelvic computer tomography. The patient was subsequently admitted and developed worsening right lower quadrant abdominal pain and distention overnight. Due to this worsening clinical condition, the decision was made to proceed with a diagnostic laparoscopy. After frank pus was found laparoscopically around the cecum and appendix, it was then converted to an exploratory laparotomy. Subsequently, a perforated gangrenous appendix was found with an erythematous and indurated cecum.</p><p><strong>Conclusion: </strong>Major complications of colonoscopy can include perforation and/or post-colonoscopy bleeding which have been shown to have a respective incidence of 0.21% and 0.1%. With the anticipated rise in the number of colonoscopies, much rarer complications such as PCA with an incidence of less than 0.05% will be seen more frequently. Due to its nonspecific presentation, it is necessary for providers to consider PCA as an important differential for all patients presenting with abdominal pain after a colonoscopy.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"333-339"},"PeriodicalIF":0.5,"publicationDate":"2024-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249547/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Nonagenarian Gastric Anisakiasis with Atypical Presentation. 一例表现不典型的非老年胃畸形病例
IF 0.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-06-17 eCollection Date: 2024-01-01 DOI: 10.1159/000539304
Toshio Arai, Seisuke Saito, Takahiro Kinebuchi, Koji Nishikawa, Yasuyuki Morishima, Hiromu Sugiyama

Introduction: Anisakiasis is a parasitic disease caused by larvae from anisakid nematodes. In recent years, there has been an increase in cases of anisakiasis, a relatively uncommon medical condition.

Case presentation: A 93-year-old woman with chronic heart failure developed hives and nausea 6 h after eating silver flounder sashimi, leading to suspicion of fish allergy. Despite treatment, symptoms persisted and progressed to abdominal pain. An upper gastrointestinal endoscopy revealed an Anisakis larva in her stomach, an unusual finding given her age. After endoscopic removal of the living worm, the patient's symptoms were relieved.

Conclusion: A case of atypical anisakiasis in a 93-year-old patient was demonstrated. This case underscores the importance of considering atypical presentations in clinical decision-making.

简介蛔虫病是一种由蛔线虫幼虫引起的寄生虫病。近年来,恙虫病病例不断增加,这是一种相对不常见的疾病:病例介绍:一名患有慢性心力衰竭的 93 岁妇女在食用银比目鱼生鱼片 6 小时后出现荨麻疹和恶心,怀疑对鱼过敏。尽管接受了治疗,但症状依然存在,并发展为腹痛。上消化道内窥镜检查发现她的胃里有一条疟原虫幼虫,考虑到她的年龄,这一发现并不寻常。在内镜下取出活虫后,患者的症状得到缓解:结论:这是一例在 93 岁患者体内发现的非典型阿尼萨奇虫病。本病例强调了在临床决策中考虑非典型表现的重要性。
{"title":"A Case of Nonagenarian Gastric Anisakiasis with Atypical Presentation.","authors":"Toshio Arai, Seisuke Saito, Takahiro Kinebuchi, Koji Nishikawa, Yasuyuki Morishima, Hiromu Sugiyama","doi":"10.1159/000539304","DOIUrl":"10.1159/000539304","url":null,"abstract":"<p><strong>Introduction: </strong>Anisakiasis is a parasitic disease caused by larvae from anisakid nematodes. In recent years, there has been an increase in cases of anisakiasis, a relatively uncommon medical condition.</p><p><strong>Case presentation: </strong>A 93-year-old woman with chronic heart failure developed hives and nausea 6 h after eating silver flounder sashimi, leading to suspicion of fish allergy. Despite treatment, symptoms persisted and progressed to abdominal pain. An upper gastrointestinal endoscopy revealed an <i>Anisakis</i> larva in her stomach, an unusual finding given her age. After endoscopic removal of the living worm, the patient's symptoms were relieved.</p><p><strong>Conclusion: </strong>A case of atypical anisakiasis in a 93-year-old patient was demonstrated. This case underscores the importance of considering atypical presentations in clinical decision-making.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"327-332"},"PeriodicalIF":0.5,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11250682/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Refractory Diarrhea Associated with COVID-19: A Case Report. 与 COVID-19 相关的严重难治性腹泻:病例报告。
IF 0.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-06-14 eCollection Date: 2024-01-01 DOI: 10.1159/000539413
Akiyoshi Tsuboi, Shuya Shigenobu, Yuka Matsubara, Issei Hirata, Hidenori Tanaka, Ken Yamashita, Ryo Yuge, Yuji Urabe, Koji Arihiro, Shiro Oka

Introduction: Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is frequently associated with various gastrointestinal symptoms, including abdominal pain, vomiting, and diarrhea. Moreover, several cases of refractory diarrhea have been reported after COVID-19 recovery. Herein, we present a case of severe refractory diarrhea associated with COVID-19.

Case presentation: A 50-year-old man with no comorbidities was admitted to our hospital with SARS-CoV-2 pneumonia. His respiratory status deteriorated, and ventilatory management, including extracorporeal membrane oxygenation, was needed. The patient's respiratory condition improved, resulting in a transfer to another hospital for rehabilitation. However, the patient developed diarrhea that worsened to 6,000-7,000 mL/day, and he was transferred to our hospital. We diagnosed the patient with enterocolitis caused by cytomegalovirus infection and treated him with ganciclovir on day 5 after transfer to our hospital. The diarrhea did not improve. We suspected enterocolitis associated with COVID-19 and administered a methylprednisolone pulse (intravenous injection, 1,000 mg/day for 3 days) on day 10 after transfer, resulting in a marked improvement in his symptoms. The prednisolone dose was tapered, and no recurrence of diarrhea was observed thereafter.

Conclusion: The prevalence of COVID-19-associated enterocolitis is low, and the pathogenesis of the disease remains unclear. Prednisolone administration should be considered in cases of post-COVID-19 symptoms of severe diarrhea due to a possible abnormal immune response related to COVID-19.

导言:由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的冠状病毒病 2019(COVID-19)经常伴有各种胃肠道症状,包括腹痛、呕吐和腹泻。此外,COVID-19 康复后出现难治性腹泻的病例也有多例报道。在此,我们介绍一例与 COVID-19 相关的严重难治性腹泻病例:一名无合并症的 50 岁男性因 SARS-CoV-2 肺炎入住我院。他的呼吸状况恶化,需要进行呼吸管理,包括体外膜氧合。患者的呼吸状况有所改善,因此转到另一家医院进行康复治疗。然而,患者又出现腹泻,腹泻量增加到每天 6000-7000 毫升,于是转到本院。我们诊断患者为巨细胞病毒感染引起的小肠结肠炎,并在转院后第 5 天用更昔洛韦治疗。但腹泻症状并未改善。我们怀疑小肠结肠炎与 COVID-19 有关,于是在转院后第 10 天给他注射了甲基强的松龙脉冲(静脉注射,每天 1,000 毫克,连续 3 天),结果症状明显好转。泼尼松龙剂量逐渐减少,此后腹泻没有再复发:结论:COVID-19 相关性小肠结肠炎的发病率较低,其发病机制尚不清楚。结论:COVID-19 相关性肠炎的发病率较低,发病机制尚不清楚,在出现 COVID-19 后严重腹泻症状时,应考虑使用泼尼松龙。
{"title":"Severe Refractory Diarrhea Associated with COVID-19: A Case Report.","authors":"Akiyoshi Tsuboi, Shuya Shigenobu, Yuka Matsubara, Issei Hirata, Hidenori Tanaka, Ken Yamashita, Ryo Yuge, Yuji Urabe, Koji Arihiro, Shiro Oka","doi":"10.1159/000539413","DOIUrl":"10.1159/000539413","url":null,"abstract":"<p><strong>Introduction: </strong>Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is frequently associated with various gastrointestinal symptoms, including abdominal pain, vomiting, and diarrhea. Moreover, several cases of refractory diarrhea have been reported after COVID-19 recovery. Herein, we present a case of severe refractory diarrhea associated with COVID-19.</p><p><strong>Case presentation: </strong>A 50-year-old man with no comorbidities was admitted to our hospital with SARS-CoV-2 pneumonia. His respiratory status deteriorated, and ventilatory management, including extracorporeal membrane oxygenation, was needed. The patient's respiratory condition improved, resulting in a transfer to another hospital for rehabilitation. However, the patient developed diarrhea that worsened to 6,000-7,000 mL/day, and he was transferred to our hospital. We diagnosed the patient with enterocolitis caused by cytomegalovirus infection and treated him with ganciclovir on day 5 after transfer to our hospital. The diarrhea did not improve. We suspected enterocolitis associated with COVID-19 and administered a methylprednisolone pulse (intravenous injection, 1,000 mg/day for 3 days) on day 10 after transfer, resulting in a marked improvement in his symptoms. The prednisolone dose was tapered, and no recurrence of diarrhea was observed thereafter.</p><p><strong>Conclusion: </strong>The prevalence of COVID-19-associated enterocolitis is low, and the pathogenesis of the disease remains unclear. Prednisolone administration should be considered in cases of post-COVID-19 symptoms of severe diarrhea due to a possible abnormal immune response related to COVID-19.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"318-326"},"PeriodicalIF":0.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11250576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastrointestinal Symptom-Free Multiple Lymphomatous Polyposis: An Atypical Case Presentation of Mantle Cell Lymphoma. 无胃肠道症状的多发性淋巴瘤性息肉病:套细胞淋巴瘤的非典型病例。
IF 0.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-06-13 eCollection Date: 2024-01-01 DOI: 10.1159/000539288
Rahil Desai, Katherine Khazey, Hasnoor Sandhu, Peter Makar, Navkiran Randhawa, Ahamed Khalyfa, Mahnoor Khan, Alex Yarbrough, Tilemahos Spyratos

Introduction: Mantle cell lymphoma (MCL), a rare non-Hodgkin's lymphoma, exhibits a genetic translocation causing CCND1 gene overexpression, affecting 5% of NHL cases, predominantly in males aged 60-70. Typically diagnosed with advanced symptoms, MCL involves widespread disease and organ spread, being aggressive and incurable with a 1.8-9.4-year average survival. Optimal treatment depends on disease aggressiveness and age. Multiple lymphomatous polyposis (MLP), a rare MCL subtype in the GI tract, is usually present with GI symptoms.

Case presentation: A 71-year-old woman was diagnosed with asymptomatic MLP during MCL staging who underwent thoracentesis due to large right pleural effusion and significant axillary lymphadenopathy and was treated with a chemotherapy regimen of rituximab/cytarabine and later transitioned to bendamustine/rituximab. This patient eventually underwent a bone marrow biopsy and later a bone marrow transplant.

Conclusion: We present a unique case of asymptomatic MLP, emphasizing the importance of early detection for the poor prognosis of MLP with a mean survival of less than 3 years.

简介:套细胞淋巴瘤(MCL)是一种罕见的非霍奇金淋巴瘤:套细胞淋巴瘤(MCL)是一种罕见的非霍奇金淋巴瘤,其基因易位导致CCND1基因过度表达,占NHL病例的5%,主要发生于60-70岁的男性。MCL 通常在确诊时已出现晚期症状,病变范围广,可向器官扩散,具有侵袭性,无法治愈,平均生存期为 1.8-9.4 年。最佳治疗方法取决于疾病的侵袭性和年龄。多发性淋巴瘤性息肉病(MLP)是一种罕见的消化道 MCL 亚型,通常伴有消化道症状:一名71岁的妇女在MCL分期时被诊断为无症状MLP,因右侧胸腔大量积液和明显的腋窝淋巴结病而接受了胸腔穿刺术,并接受了利妥昔单抗/阿糖胞苷的化疗方案,后来又过渡到苯达莫司汀/利妥昔单抗。该患者最终接受了骨髓活检,随后进行了骨髓移植:我们介绍了一例独特的无症状MLP病例,强调了早期发现的重要性,因为MLP预后较差,平均存活期不到3年。
{"title":"Gastrointestinal Symptom-Free Multiple Lymphomatous Polyposis: An Atypical Case Presentation of Mantle Cell Lymphoma.","authors":"Rahil Desai, Katherine Khazey, Hasnoor Sandhu, Peter Makar, Navkiran Randhawa, Ahamed Khalyfa, Mahnoor Khan, Alex Yarbrough, Tilemahos Spyratos","doi":"10.1159/000539288","DOIUrl":"10.1159/000539288","url":null,"abstract":"<p><strong>Introduction: </strong>Mantle cell lymphoma (MCL), a rare non-Hodgkin's lymphoma, exhibits a genetic translocation causing CCND1 gene overexpression, affecting 5% of NHL cases, predominantly in males aged 60-70. Typically diagnosed with advanced symptoms, MCL involves widespread disease and organ spread, being aggressive and incurable with a 1.8-9.4-year average survival. Optimal treatment depends on disease aggressiveness and age. Multiple lymphomatous polyposis (MLP), a rare MCL subtype in the GI tract, is usually present with GI symptoms.</p><p><strong>Case presentation: </strong>A 71-year-old woman was diagnosed with asymptomatic MLP during MCL staging who underwent thoracentesis due to large right pleural effusion and significant axillary lymphadenopathy and was treated with a chemotherapy regimen of rituximab/cytarabine and later transitioned to bendamustine/rituximab. This patient eventually underwent a bone marrow biopsy and later a bone marrow transplant.</p><p><strong>Conclusion: </strong>We present a unique case of asymptomatic MLP, emphasizing the importance of early detection for the poor prognosis of MLP with a mean survival of less than 3 years.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"313-317"},"PeriodicalIF":0.5,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11250683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141629689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurofibromatosis Type 1 Presenting as Bleeding Jejunal Gastrointestinal Stromal Tumour. 神经纤维瘤病 1 型表现为出血性空肠胃肠道间质瘤。
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-06-07 eCollection Date: 2024-01-01 DOI: 10.1159/000538688
Raymond Fueng-Hin Liang, Cora Yuk-Ping Chau, Wee Chian Lim

Introduction: Gastrointestinal stromal tumours (GISTs) are an important, though uncommon, cause of obscure gastrointestinal bleeding and may rarely be associated with genodermatoses such as neurofibromatosis type 1 (NF1). NF1-related GISTs have unique phenotypic features compared with sporadic GISTs and may elude diagnosis due to their predilection for the small bowel.

Case presentation: We report a case of a 45-year-old Singaporean woman with café-au-lait macules and cutaneous neurofibromas who presented with occult obscure gastrointestinal bleeding and was eventually discovered to have a bleeding jejunal GIST. This finding, considered together with her cutaneous signs, eventually led to the diagnosis of NF1.

Conclusion: Genodermatoses and their gastrointestinal complications are likely under-reported in adult Southeast Asian populations and deserve greater awareness from gastroenterologists practising in this region.

导言:胃肠道间质瘤(GISTs)是导致隐匿性胃肠道出血的一个重要原因,尽管并不常见,但很少与1型神经纤维瘤病(NF1)等遗传性皮肤病有关。与散发性 GIST 相比,与 NF1 相关的 GIST 具有独特的表型特征,并且由于其偏爱小肠而可能无法确诊:我们报告了一例 45 岁的新加坡妇女的病例,她患有咖啡色斑块和皮肤神经纤维瘤,并伴有隐匿性消化道出血,最终被发现患有出血的空肠 GIST。考虑到这一发现以及她的皮肤症状,最终确诊为 NF1:结论:遗传性皮肤病及其胃肠道并发症在东南亚成年人群中的报告率可能偏低,值得在该地区执业的消化内科医生进一步关注。
{"title":"Neurofibromatosis Type 1 Presenting as Bleeding Jejunal Gastrointestinal Stromal Tumour.","authors":"Raymond Fueng-Hin Liang, Cora Yuk-Ping Chau, Wee Chian Lim","doi":"10.1159/000538688","DOIUrl":"10.1159/000538688","url":null,"abstract":"<p><strong>Introduction: </strong>Gastrointestinal stromal tumours (GISTs) are an important, though uncommon, cause of obscure gastrointestinal bleeding and may rarely be associated with genodermatoses such as neurofibromatosis type 1 (NF1). NF1-related GISTs have unique phenotypic features compared with sporadic GISTs and may elude diagnosis due to their predilection for the small bowel.</p><p><strong>Case presentation: </strong>We report a case of a 45-year-old Singaporean woman with café-au-lait macules and cutaneous neurofibromas who presented with occult obscure gastrointestinal bleeding and was eventually discovered to have a bleeding jejunal GIST. This finding, considered together with her cutaneous signs, eventually led to the diagnosis of NF1.</p><p><strong>Conclusion: </strong>Genodermatoses and their gastrointestinal complications are likely under-reported in adult Southeast Asian populations and deserve greater awareness from gastroenterologists practising in this region.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"299-305"},"PeriodicalIF":0.6,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141417906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent Upper Gastrointestinal Bleeding due to Radiation-Induced Hemorrhagic Gastroduodenal Ectasia: A Review of Current Treatment Options for Radiation-Induced Gastric Injury. 放射线诱发出血性胃十二指肠外翻导致的复发性上消化道出血:放射线诱发胃损伤的现有治疗方案综述。
IF 0.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-06-07 eCollection Date: 2024-01-01 DOI: 10.1159/000538965
Simone A Jarrett, Rushi Kaushik Talati, Johann Hasbun, Wenqing Cao, Scott M Smukalla

Introduction: Acute upper gastrointestinal bleeding is one of the most common medical emergencies that present to the hospital, and delineating the underlying etiology is essential to provide adequate definitive treatment. The purpose of this case report was to review the diagnosis and treatment of a rare complication known as radiation-induced hemorrhagic gastritis (RIHG) that can occur in patients with prior radiation exposure. The motivation for this study arose from the identification of a case within our institution.

Case presentation: The study involved a review of the diagnosis and management of a patient who presented with anemia and recurrent episodes of gastrointestinal bleeding at our institution after undergoing treatment for metastatic biliary adenocarcinoma. With the advent of new therapies, we aimed to investigate the various techniques utilized to manage these patients and highlight the importance of maintaining a high index of suspicion for RIHG as a potential etiology of gastrointestinal bleeding in patients with a relevant medical history of radiation exposure. Despite the literature review, we found that there is a lack of guidelines in the approach to the management of these patients.

Conclusion: This case report underscores the rarity of radiation-induced gastritis and the complications that may arise from its diagnosis, including recurrent GI bleeding. Further investigation into identifying definitive treatment and creating guidelines for its management is desperately needed.

导言:急性上消化道出血是医院最常见的急诊病人之一,明确病因对提供适当的明确治疗至关重要。本病例报告旨在回顾放射线诱发出血性胃炎(RIHG)这一罕见并发症的诊断和治疗。本研究的动机源于我院发现的一例病例:本研究回顾了一名患者的诊断和治疗过程,该患者在接受转移性胆道腺癌治疗后出现贫血和反复发作的消化道出血。随着新疗法的出现,我们旨在研究用于治疗这些患者的各种技术,并强调对有相关辐射病史的患者保持高度怀疑 RIHG 作为消化道出血潜在病因的重要性。尽管进行了文献综述,但我们发现在这些患者的管理方法方面缺乏指南:本病例报告强调了辐射诱发胃炎的罕见性以及诊断后可能出现的并发症,包括复发性消化道出血。我们亟需进一步研究确定明确的治疗方法,并制定治疗指南。
{"title":"Recurrent Upper Gastrointestinal Bleeding due to Radiation-Induced Hemorrhagic Gastroduodenal Ectasia: A Review of Current Treatment Options for Radiation-Induced Gastric Injury.","authors":"Simone A Jarrett, Rushi Kaushik Talati, Johann Hasbun, Wenqing Cao, Scott M Smukalla","doi":"10.1159/000538965","DOIUrl":"10.1159/000538965","url":null,"abstract":"<p><strong>Introduction: </strong>Acute upper gastrointestinal bleeding is one of the most common medical emergencies that present to the hospital, and delineating the underlying etiology is essential to provide adequate definitive treatment. The purpose of this case report was to review the diagnosis and treatment of a rare complication known as radiation-induced hemorrhagic gastritis (RIHG) that can occur in patients with prior radiation exposure. The motivation for this study arose from the identification of a case within our institution.</p><p><strong>Case presentation: </strong>The study involved a review of the diagnosis and management of a patient who presented with anemia and recurrent episodes of gastrointestinal bleeding at our institution after undergoing treatment for metastatic biliary adenocarcinoma. With the advent of new therapies, we aimed to investigate the various techniques utilized to manage these patients and highlight the importance of maintaining a high index of suspicion for RIHG as a potential etiology of gastrointestinal bleeding in patients with a relevant medical history of radiation exposure. Despite the literature review, we found that there is a lack of guidelines in the approach to the management of these patients.</p><p><strong>Conclusion: </strong>This case report underscores the rarity of radiation-induced gastritis and the complications that may arise from its diagnosis, including recurrent GI bleeding. Further investigation into identifying definitive treatment and creating guidelines for its management is desperately needed.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"306-312"},"PeriodicalIF":0.5,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249716/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis and Vasodilatory Shock due to an Unsuspected Culprit: A Rare Presentation of Multisystem Langerhans Cell Histiocytosis. 不明原因的肝炎和血管舒张性休克:多系统朗格汉斯细胞组织细胞增生症的罕见表现
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-05-31 eCollection Date: 2024-01-01 DOI: 10.1159/000538794
Shubhang K Bhatt, Nikita Ashcherkin, John Fanous, Rish K Pai, Janhavi Athale

Introduction: Langerhans cell histiocytosis (LCH) is a rare hematologic condition which can affect multiple organ systems and has variable presentation. LCH is more commonly seen as a malignancy of childhood. LCH in adulthood can have poor outcomes depending on the involvement of critical organs.

Case presentation: We report a case of a 71-year-old female who presented with progressive weakness, weight loss, diarrhea, and jaundice, and had been undergoing outpatient workup for elevated liver enzymes for the last 2 years. She required admission to the intensive care unit for vasodilatory shock, requiring vasopressor and chronotropic support. Imaging showed an underlying multiorgan process involving the gastrointestinal tract, liver, spleen, and central nervous system. A repeat liver biopsy after a prior inconclusive one revealed the diagnosis of multisystem LCH presenting as secondary sclerosing cholangitis.

Conclusion: The uniqueness of this multisystem LCH case lies not only in its rarity but also in the diagnostic journey that necessitated a repeat biopsy for a conclusive diagnosis. Early identification and targeted intervention can help in ensuring better patient outcomes, especially when the presentation can overlap with various other possible conditions.

简介朗格汉斯细胞组织细胞增生症(Langerhans cell histiocytosis,LCH)是一种罕见的血液病,可累及多个器官系统,表现各异。朗格汉斯细胞组织细胞增生症多见于儿童时期的恶性肿瘤。成年期的 LCH 可因累及重要器官而导致不良后果:我们报告了一例 71 岁女性的病例,她出现了进行性乏力、体重减轻、腹泻和黄疸,过去两年一直在门诊接受肝酶升高的检查。她因血管舒张性休克被送入重症监护室,需要使用血管加压素和促肾上腺皮质激素。影像学检查显示,她的胃肠道、肝脏、脾脏和中枢神经系统都存在潜在的多器官病变。在进行了一次不确定的肝活检后,再次进行的肝活检显示,诊断结果为多系统LCH,表现为继发性硬化性胆管炎:这个多系统 LCH 病例的独特之处不仅在于它的罕见性,还在于它的诊断过程需要重复活检才能确诊。早期识别和有针对性的干预有助于确保患者获得更好的治疗效果,尤其是当患者的症状可能与其他各种疾病重叠时。
{"title":"Hepatitis and Vasodilatory Shock due to an Unsuspected Culprit: A Rare Presentation of Multisystem Langerhans Cell Histiocytosis.","authors":"Shubhang K Bhatt, Nikita Ashcherkin, John Fanous, Rish K Pai, Janhavi Athale","doi":"10.1159/000538794","DOIUrl":"10.1159/000538794","url":null,"abstract":"<p><strong>Introduction: </strong>Langerhans cell histiocytosis (LCH) is a rare hematologic condition which can affect multiple organ systems and has variable presentation. LCH is more commonly seen as a malignancy of childhood. LCH in adulthood can have poor outcomes depending on the involvement of critical organs.</p><p><strong>Case presentation: </strong>We report a case of a 71-year-old female who presented with progressive weakness, weight loss, diarrhea, and jaundice, and had been undergoing outpatient workup for elevated liver enzymes for the last 2 years. She required admission to the intensive care unit for vasodilatory shock, requiring vasopressor and chronotropic support. Imaging showed an underlying multiorgan process involving the gastrointestinal tract, liver, spleen, and central nervous system. A repeat liver biopsy after a prior inconclusive one revealed the diagnosis of multisystem LCH presenting as secondary sclerosing cholangitis.</p><p><strong>Conclusion: </strong>The uniqueness of this multisystem LCH case lies not only in its rarity but also in the diagnostic journey that necessitated a repeat biopsy for a conclusive diagnosis. Early identification and targeted intervention can help in ensuring better patient outcomes, especially when the presentation can overlap with various other possible conditions.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"286-292"},"PeriodicalIF":0.6,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11167066/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Two Cases of Increased Gastrointestinal Polyps in Familial Adenomatous Polyposis following Antiacid Agent Intake. 两例家族性腺瘤性息肉病患者在摄入抗酸剂后胃肠道息肉增加
IF 0.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-05-31 eCollection Date: 2024-01-01 DOI: 10.1159/000538833
Yuji Urabe, Hideki Ishikawa, Akira Ishikawa, Shingo Ishiguro, Kazuki Ishibashi, Koji Arihiro, Michihiro Mutoh, Shiro Oka

Introduction: Familial adenomatous polyposis (FAP), a hereditary disorder of the gastrointestinal tract, is an autosomal dominant inherited condition caused by germline mutations in the adenomatous polyposis coli (APC) gene. It is characterized by the development of hundreds to thousands of colorectal adenomatous polyps, which, if left untreated, can eventually develop into colorectal carcinomas. Representative extracolonic tumors in FAP include multiple duodenal adenomas and desmoid tumors. Moreover, multiple fundic gland polyps are frequently identified in the stomachs of patients with FAP.

Case presentation: Herein, we report the two cases. A 52-year-old woman who underwent total colectomy for FAP, and pancreatoduodenectomy was initiated on esomeprazole for the treatment of anastomotic erosion. Esophagogastroduodenoscopy performed 42 months later showed an increased number and size of gastric fundic gland polyps, which subsequently decreased after replacing esomeprazole with ranitidine. Similarly, a 39-year-old woman with FAP was initiated on vonoprazan for the treatment of reflux symptoms. Esophagogastroduodenoscopy and colonoscopy performed 14 months later indicated an increase in the number of gastric fundic gland polyps and colorectal polyps, which subsequently decreased after vonoprazan discontinuation. In these two cases, the increase and decrease in the number and size of fundic gland polyps and colon adenoma were associated with serum gastrin levels.

Conclusion: Gastric fundic gland polyps and colon polyps may rapidly increase in number and size due to increased gastrin levels induced by proton pump inhibitor/potassium-competitive acid blocker use. Hence, these drugs should be prescribed with caution.

简介:家族性腺瘤性息肉病(FAP)是一种遗传性胃肠道疾病:家族性腺瘤性息肉病(FAP)是一种遗传性胃肠道疾病,是一种常染色体显性遗传病,由腺瘤性息肉病大肠杆菌(APC)基因的种系突变引起。其特点是会出现数百至数千个结直肠腺瘤性息肉,如果不及时治疗,这些息肉最终会发展成结直肠癌。FAP 中具有代表性的结肠外肿瘤包括多发性十二指肠腺瘤和类苔藓样瘤。此外,FAP 患者的胃中还经常发现多发性胃底腺息肉:在此,我们报告了两个病例。一名 52 岁的女性因 FAP 接受了全结肠切除术和胰十二指肠切除术,为了治疗吻合口糜烂,她开始服用埃索美拉唑。42 个月后进行的食管胃十二指肠镜检查显示,胃底腺息肉的数量和大小有所增加,但在用雷尼替丁取代埃索美拉唑后,息肉数量和大小随之减少。同样,一名患有 FAP 的 39 岁女性也开始服用沃诺普拉赞治疗反流症状。14 个月后进行的食管胃十二指肠镜检查和结肠镜检查显示,胃底腺息肉和结肠直肠息肉数量增加,停用伏诺普拉赞后息肉数量减少。在这两个病例中,胃底腺息肉和结肠腺瘤数量和大小的增减与血清胃泌素水平有关:结论:使用质子泵抑制剂/钾竞争性酸阻滞剂会导致胃泌素水平升高,从而使胃底腺息肉和结肠息肉的数量和大小迅速增加。因此,应慎用这些药物。
{"title":"Two Cases of Increased Gastrointestinal Polyps in Familial Adenomatous Polyposis following Antiacid Agent Intake.","authors":"Yuji Urabe, Hideki Ishikawa, Akira Ishikawa, Shingo Ishiguro, Kazuki Ishibashi, Koji Arihiro, Michihiro Mutoh, Shiro Oka","doi":"10.1159/000538833","DOIUrl":"10.1159/000538833","url":null,"abstract":"<p><strong>Introduction: </strong>Familial adenomatous polyposis (FAP), a hereditary disorder of the gastrointestinal tract, is an autosomal dominant inherited condition caused by germline mutations in the adenomatous polyposis coli (<i>APC</i>) gene. It is characterized by the development of hundreds to thousands of colorectal adenomatous polyps, which, if left untreated, can eventually develop into colorectal carcinomas. Representative extracolonic tumors in FAP include multiple duodenal adenomas and desmoid tumors. Moreover, multiple fundic gland polyps are frequently identified in the stomachs of patients with FAP.</p><p><strong>Case presentation: </strong>Herein, we report the two cases. A 52-year-old woman who underwent total colectomy for FAP, and pancreatoduodenectomy was initiated on esomeprazole for the treatment of anastomotic erosion. Esophagogastroduodenoscopy performed 42 months later showed an increased number and size of gastric fundic gland polyps, which subsequently decreased after replacing esomeprazole with ranitidine. Similarly, a 39-year-old woman with FAP was initiated on vonoprazan for the treatment of reflux symptoms. Esophagogastroduodenoscopy and colonoscopy performed 14 months later indicated an increase in the number of gastric fundic gland polyps and colorectal polyps, which subsequently decreased after vonoprazan discontinuation. In these two cases, the increase and decrease in the number and size of fundic gland polyps and colon adenoma were associated with serum gastrin levels.</p><p><strong>Conclusion: </strong>Gastric fundic gland polyps and colon polyps may rapidly increase in number and size due to increased gastrin levels induced by proton pump inhibitor/potassium-competitive acid blocker use. Hence, these drugs should be prescribed with caution.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"293-298"},"PeriodicalIF":0.5,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11250236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peribiliary Gland Hyperplasia That Required Differentiation from Extrahepatic Bile Duct Cancer: A Case Report. 需要与肝外胆管癌鉴别的胆管周围腺体增生:病例报告。
IF 0.5 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-05-23 eCollection Date: 2024-01-01 DOI: 10.1159/000538491
Kazuhiro Takami, Kuniharu Yamamoto, Hiroto Sakurai, Yoshihiro Sato, Noriko Kondo, Toru Nakano, Shingo Tsujinaka, Akinobu Koiwai, Morihisa Hirota, Keigo Murakami, Kazuhiro Murakami, Chikashi Shibata, Yu Katayose

Introduction: The peribiliary gland is an accessory bile duct gland. Hyperplasia of these tissues may lead to elevation of the mucosa in the bile ducts and bile duct stenosis. We herein report a case of peribiliary gland hyperplasia that required preoperative differentiation from bile duct cancer, with a discussion of the literature.

Case presentation: The patient had an adenomatous lesion in the ascending colon that was difficult to treat endoscopically; therefore, surgery was planned. Preoperative abdominal ultrasonography revealed a bile duct tumor, and endoscopic ultrasonography revealed a mass lesion around the confluence of the cystic duct. Computed tomography revealed localized wall thickening in the middle bile duct, and the upstream bile ducts were slightly dilated. In addition, continuous thickening of the bile duct wall from the gallbladder to the confluence of the cystic duct was observed. No distant metastases, such as liver metastases, or nearby enlarged lymph nodes were observed. Endoscopic retrograde cholangiopancreatography and magnetic resonance cholangiopancreatography revealed a papillary-like elevated lesion in the bile duct near the confluence of the cystic duct, and a biopsy and bile cytology from the same area showed no malignant findings. As a result, the possibility that the patient had gallbladder or bile duct cancer could not be ruled out; therefore, a policy of surgery together with the ascending colon tumor was decided after receiving sufficient informed consent. During surgery, the patient underwent extrahepatic bile duct resection, reconstruction of the biliary tract using the Roux-en-Y method, and right hemicolectomy. Both duodenal and hilar bile duct transects were subjected to a fast frozen section analysis during surgery, and the results were negative for cancer. A histopathological examination of the resected specimen revealed no malignant findings in the bile duct lesions, and a diagnosis of peribiliary gland hyperplasia with chronic inflammatory cell infiltration and fibrosis of the extrahepatic bile duct wall was made.

Conclusions: We encountered a case of peribiliary gland hyperplasia that was difficult to distinguish from bile duct cancer.

导言:胆管周围腺体是胆管的附属腺体。这些组织的增生可能导致胆管粘膜隆起和胆管狭窄。我们在此报告一例胆管周围腺增生病例,该病例需要在术前与胆管癌进行鉴别,并对文献进行了讨论:患者升结肠有一处腺瘤性病变,难以通过内镜治疗,因此计划进行手术。术前腹部超声波检查发现了胆管肿瘤,内镜超声波检查发现了胆囊管汇合处的肿块病变。计算机断层扫描显示中胆管局部管壁增厚,上游胆管轻度扩张。此外,还观察到从胆囊到胆囊管汇合处的胆管壁持续增厚。未发现远处转移(如肝转移)或附近淋巴结肿大。内镜逆行胰胆管造影和磁共振胰胆管造影显示,胆囊管汇合处附近的胆管内有乳头状隆起病变,同一部位的活检和胆汁细胞学检查未发现恶性病变。因此,不能排除患者患有胆囊癌或胆管癌的可能性,所以在征得患者充分知情同意后,决定对其进行升结肠肿瘤一并手术治疗。手术期间,患者接受了肝外胆管切除术,采用 Roux-en-Y 方法重建胆道,并进行了右半结肠切除术。手术期间对十二指肠和肝门胆管横断面进行了快速冰冻切片分析,结果显示癌症阴性。切除标本的组织病理学检查显示胆管病变无恶性发现,诊断为胆管周围腺体增生伴慢性炎症细胞浸润和肝外胆管壁纤维化:结论:我们遇到了一例胆管周围腺体增生症与胆管癌难以区分的病例。
{"title":"Peribiliary Gland Hyperplasia That Required Differentiation from Extrahepatic Bile Duct Cancer: A Case Report.","authors":"Kazuhiro Takami, Kuniharu Yamamoto, Hiroto Sakurai, Yoshihiro Sato, Noriko Kondo, Toru Nakano, Shingo Tsujinaka, Akinobu Koiwai, Morihisa Hirota, Keigo Murakami, Kazuhiro Murakami, Chikashi Shibata, Yu Katayose","doi":"10.1159/000538491","DOIUrl":"10.1159/000538491","url":null,"abstract":"<p><strong>Introduction: </strong>The peribiliary gland is an accessory bile duct gland. Hyperplasia of these tissues may lead to elevation of the mucosa in the bile ducts and bile duct stenosis. We herein report a case of peribiliary gland hyperplasia that required preoperative differentiation from bile duct cancer, with a discussion of the literature.</p><p><strong>Case presentation: </strong>The patient had an adenomatous lesion in the ascending colon that was difficult to treat endoscopically; therefore, surgery was planned. Preoperative abdominal ultrasonography revealed a bile duct tumor, and endoscopic ultrasonography revealed a mass lesion around the confluence of the cystic duct. Computed tomography revealed localized wall thickening in the middle bile duct, and the upstream bile ducts were slightly dilated. In addition, continuous thickening of the bile duct wall from the gallbladder to the confluence of the cystic duct was observed. No distant metastases, such as liver metastases, or nearby enlarged lymph nodes were observed. Endoscopic retrograde cholangiopancreatography and magnetic resonance cholangiopancreatography revealed a papillary-like elevated lesion in the bile duct near the confluence of the cystic duct, and a biopsy and bile cytology from the same area showed no malignant findings. As a result, the possibility that the patient had gallbladder or bile duct cancer could not be ruled out; therefore, a policy of surgery together with the ascending colon tumor was decided after receiving sufficient informed consent. During surgery, the patient underwent extrahepatic bile duct resection, reconstruction of the biliary tract using the Roux-en-Y method, and right hemicolectomy. Both duodenal and hilar bile duct transects were subjected to a fast frozen section analysis during surgery, and the results were negative for cancer. A histopathological examination of the resected specimen revealed no malignant findings in the bile duct lesions, and a diagnosis of peribiliary gland hyperplasia with chronic inflammatory cell infiltration and fibrosis of the extrahepatic bile duct wall was made.</p><p><strong>Conclusions: </strong>We encountered a case of peribiliary gland hyperplasia that was difficult to distinguish from bile duct cancer.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"279-285"},"PeriodicalIF":0.5,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11249448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Side Effects of Stem Cell Transplant Mimicking Symptoms of Known Amyloidosis. 模仿已知淀粉样变性症状的干细胞移植副作用。
IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-05-21 eCollection Date: 2024-01-01 DOI: 10.1159/000538947
Gabriel Heering, Zilan Lin, Michael Rosman, Nao Hara, Fouzia Shakil, Dimitrios Georgostathis

Introduction: AL amyloidosis can involve the gastrointestinal (GI) tract in a sporadic manner, affecting certain anatomical areas while sparing others.

Case presentation: Our patient with AL amyloidosis and confirmed colonic involvement was found to have new odynophagia, GI bleeding, and imaging findings that might suggest AL amyloidosis. However, negative pathology results from esophageal biopsies suggested the patient's new ulcerations were more likely a side effect of her autologous stem cell transplant (SCT) and chemotherapy meant to target amyloidosis, as opposed to an effect of amyloid infiltration itself.

Conclusion: GI involvement of amyloidosis requires a high degree of clinical suspicion and should be considered in patients with systemic diseases affecting the kidney, heart, and GI tract; however, when satisfactory biopsies obtained from endoscopy results are negative, other causes should be considered.

导言:AL淀粉样变性可能以散发性方式累及胃肠道(GI),影响某些解剖区域,而其他区域则不受影响:我们的患者患有 AL 淀粉样变性并确诊为结肠受累,但发现新的吞咽困难、消化道出血和影像学检查结果可能提示 AL 淀粉样变性。然而,食管活检的阴性病理结果表明,患者的新溃疡更可能是自体干细胞移植(SCT)和针对淀粉样变性的化疗的副作用,而非淀粉样变性浸润本身的影响:结论:临床上需要高度怀疑淀粉样变性的消化道受累,如果患者患有影响肾脏、心脏和消化道的全身性疾病,则应考虑淀粉样变性的消化道受累。
{"title":"Side Effects of Stem Cell Transplant Mimicking Symptoms of Known Amyloidosis.","authors":"Gabriel Heering, Zilan Lin, Michael Rosman, Nao Hara, Fouzia Shakil, Dimitrios Georgostathis","doi":"10.1159/000538947","DOIUrl":"10.1159/000538947","url":null,"abstract":"<p><strong>Introduction: </strong>AL amyloidosis can involve the gastrointestinal (GI) tract in a sporadic manner, affecting certain anatomical areas while sparing others.</p><p><strong>Case presentation: </strong>Our patient with AL amyloidosis and confirmed colonic involvement was found to have new odynophagia, GI bleeding, and imaging findings that might suggest AL amyloidosis. However, negative pathology results from esophageal biopsies suggested the patient's new ulcerations were more likely a side effect of her autologous stem cell transplant (SCT) and chemotherapy meant to target amyloidosis, as opposed to an effect of amyloid infiltration itself.</p><p><strong>Conclusion: </strong>GI involvement of amyloidosis requires a high degree of clinical suspicion and should be considered in patients with systemic diseases affecting the kidney, heart, and GI tract; however, when satisfactory biopsies obtained from endoscopy results are negative, other causes should be considered.</p>","PeriodicalId":9614,"journal":{"name":"Case Reports in Gastroenterology","volume":"18 1","pages":"273-278"},"PeriodicalIF":0.6,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11175601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141316800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Case Reports in Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1